康乃德生物 | SC 13D/A:超过5%持股股东披露文件(修正)-Panacea Innovation Limited(21.8%),Panacea Venture Healthcare Fund II, L.P.(21.8%)等
02/28 10:02
康乃德生物 | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%)等
02/28 05:28
康乃德生物 | SC 13D:超过5%持股股东披露文件-Panacea Innovation Limited(16.2%),Panacea Venture Healthcare Fund II, L.P.(16.2%)等
02/14 05:38
康乃德生物 | SC 13G/A:超过5%持股股东披露文件(修正)-Wubin Pan(12.1%),BioFortune Inc(11.2%)
02/14 05:32
康乃德生物 | SC 13G/A:超过5%持股股东披露文件(修正)-Zheng Wei(11.7%)
02/14 05:29
康乃德生物 | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(5.6%),Peter Kolchinsky(5.6%)等
2023/12/21 05:30
康乃德生物 | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(9.3%),Peter Kolchinsky(9.3%)等
2023/12/15 05:30
康乃德生物 | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(10.8%),Peter Kolchinsky(10.8%)等
2023/12/05 06:20
康乃德生物 | SC 13G/A:超过5%持股股东披露文件(修正)-Panacea Innovation Limited(10.9%),Panacea Venture Healthcare Fund II, L.P.(10.9%)等
2023/10/05 05:26
康乃德生物 | SC 13G/A:超过5%持股股东披露文件(修正)-Qiming Corporate GP V, Ltd(5.8%),Qiming GP V, L.P.(5.6%)等
2023/02/14 19:27
康乃德生物 | SC 13G:超过5%持股股东披露文件-Shanghai Minhui Enterprise Management Consulting Partnership (Limited Partnership)(9.6%),Suzhou Xiangtang Venture Investment Limited(9.6%)等
2023/02/14 06:20
康乃德生物 | SC 13G/A:超过5%持股股东披露文件(修正)-Zheng Wei(11.3%)
2023/02/14 06:13
康乃德生物 | SC 13G/A:超过5%持股股东披露文件(修正)-Wubin Pan(11.3%),BioFortune Inc.(10.7%)
2023/02/14 06:13
康乃德生物 | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(0.000%),Abigail P. Johnson(0.000%)
2023/02/09 22:59
康乃德生物 | SC 13G:超过5%持股股东披露文件-Panacea Opportunity Fund I, L.P.(5.1%),Panacea Opportunity Fund I GP Company, Ltd.(5.1%)等
2023/01/04 05:31
康乃德生物 | SC 13G:超过5%持股股东披露文件-Zheng Wei(11.0%)
2022/02/26 05:43
康乃德生物 | SC 13G:超过5%持股股东披露文件-Wubin Pan(11.1%),BioFortune Inc.(10.8%)
2022/02/26 05:42
康乃德生物 | SC 13G:超过5%持股股东披露文件-Advantech Capital II L.P.(8.5%),Advantech Capital II Connect Partnership L.P.(8.5%)等
2022/02/15 19:05
康乃德生物 | SC 13G:超过5%持股股东披露文件-Qiming Corporate GP V, Ltd(5.8%),Qiming GP V, L.P.(5.6%)等
2022/02/14 19:13
康乃德生物 | SC 13G:超过5%持股股东披露文件-FMR LLC(6.335%),Abigail P. Johnson(6.335%)
2022/02/09 22:11
暂无数据
暂无数据